Technological watch

Chromosomal integration and expression of the genes encoding a bacterial P450 and two redox partners in recombinant E. coli strains resulted in up to 80% higher (S)?ketamine conversion and more than 4?fold increase in total turnover numbers compared to the respective plasmid?based expression systems.Cytochromes P450 are useful biocatalysts in synthetic chemistry and important bio?bricks in synthetic biology. Almost all bacterial P450s require separate redox partners for their activity, which are often expressed in recombinant Escherichia coli using multiple plasmids. However, the application of CRISPR/Cas recombineering facilitated chromosomal integration of heterologous genes which enables more stable and tunable expression of multi?component P450 systems for whole?cell biotransformations. Herein, we compared three E. coli strains W3110, JM109, and BL21(DE3) harboring three heterologous genes encoding a P450 and two redox partners either on plasmids or after chromosomal integration in two genomic loci. Both loci proved to be reliable and comparable for the model regio? and stereoselective two?step oxidation of (S)?ketamine. Furthermore, the CRISPR/Cas?assisted integration of the T7 RNA polymerase gene enabled an easy extension of T7 expression strains. Higher titers of soluble active P450 were achieved in E. coli harboring a single chromosomal copy of the P450 gene compared to E. coli carrying a medium copy pET plasmid. In addition, improved expression of both redox partners after chromosomal integration resulted in up to 80% higher (S)?ketamine conversion and more than fourfold increase in total turnover numbers.